Carol Loescher, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 414 N Fant St, Anderson, SC 29621 Phone: 864-226-1294 |
Shannon Bledsoe, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 Perpetual Sq, Anderson, SC 29621 Phone: 864-512-5880 Fax: 864-375-1347 |
Michael Rivera, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1519 N Fant St, Anderson, SC 29621 Phone: 864-261-3999 Fax: 864-224-8379 |
Kara J.p. Shrum, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 2200, Anderson, SC 29621 Phone: 864-512-7500 Fax: 864-512-7575 |
Allison Gratzer Chandler, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 Perpetual Sq, Anderson, SC 29621 Phone: 864-512-5880 Fax: 864-375-1347 |
Dr. David Griffin, M.D. Obstetrics & Gynecology - Gynecologic Oncology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Cancer Center 3rd Floor, Anderson, SC 29621 Phone: 864-225-5131 Fax: 864-225-2592 |
Jonathan David Parker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 Perpetual Square Drive, Anderson, SC 29621 Phone: 864-512-5880 Fax: 864-375-1347 |
Christine Mcmahan, NP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Cancer Center 3rd Floor, Anderson, SC 29621 Phone: 864-225-5131 Fax: 864-225-2592 |
Mark Lacy, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Suite 4500, Anderson, SC 29621 Phone: 864-512-4500 Fax: 864-512-4505 |
Andrew D Clark, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 Perpetual Sq, Anderson, SC 29621 Phone: 864-512-5880 Fax: 864-375-1347 |
Timothy Duniho, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 4500, Anderson, SC 29621 Phone: 864-512-4500 Fax: 864-512-4505 |
James O. Herbert, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Suite 2550, Anderson, SC 29621 Phone: 864-225-5131 Fax: 864-225-2592 |
Dr. Henry B Hearn Iv, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 4500, Anderson, SC 29621 Phone: 864-512-4500 Fax: 864-512-4505 |
Mandy L Mitchell, MD Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 4500, Anderson, SC 29621 Phone: 864-512-4500 Fax: 864-512-4505 |
News Archive
New research shows that repeated treatments of botulinum toxin type A (BoNTA) over one year after a stroke can improve muscle tone and reduce pain in the arms and hands, making it easier for patients to dress themselves and perform personal hygiene.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, through 2019, an expanding aging population and increases in diagnosis and drug treatment will fuel steady 4.6 percent annual growth in the chronic obstructive pulmonary disease (COPD) drug market.
"It is important to put this study into context and to remember that there is a large body of previously published evidence, which suggests that Ginkgo biloba may help improve cognitive impairment in older adults. There are also additional ongoing clinical trials, the results of which may address some of the limitations of the current study. The results of this single study add to the overall data on Ginkgo biloba, including valuable evidence in support of Ginkgo's safety profile, but should not be viewed as the final word.
Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").
Halozyme Therapeutics, Inc. today announced that Roche has completed patient enrollment for the pivotal Phase 3 study of Herceptin SC (trastuzumab subcutaneous), a subcutaneous formulation that uses Halozyme's Enhanzeâ„¢ technology (rHuPH20, recombinant human hyaluronidase).
› Verified 9 days ago